Healthcare provider profile · identity verified

Jeffrey Robert Koretzky, MD

Internal Medicine · HOWELL, NJ · NPI 1942271283

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Alprazolam	Alprazolam	331	97
Levothyroxine Sodium	Levothyroxine Sodium	274	72
Clindamycin Hcl	Clindamycin Hcl	247	170
Atorvastatin Calcium	Atorvastatin Calcium	236	68
Simvastatin	Simvastatin	229	71
Metformin Hcl	Metformin Hcl	189	56
Amlodipine Besylate	Amlodipine Besylate	183	50
Metoprolol Succinate	Metoprolol Succinate	168	50
Prednisone	Prednisone	157	113
Methylprednisolone	Methylprednisolone	136	104
Albuterol Sulfate Hfa	Albuterol Sulfate	133	44
Montelukast Sodium	Montelukast Sodium	126	41
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	124	33
Rosuvastatin Calcium	Rosuvastatin Calcium	113	34
Lisinopril	Lisinopril	109	36
Fenofibrate	Fenofibrate Nanocrystallized	106	39
Losartan Potassium	Losartan Potassium	102	28
Valsartan	Valsartan	102	26
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	101	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	100	63
Zolpidem Tartrate	Zolpidem Tartrate	100	32
Pantoprazole Sodium	Pantoprazole Sodium	90	29
Ibuprofen	Ibuprofen	88	55
Sertraline Hcl	Sertraline Hcl	86	22
Olmesartan Medoxomil	Olmesartan Medoxomil	78	22
Omeprazole	Omeprazole	70	22
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	68	21
Temazepam	Temazepam	65	20
Eliquis	Apixaban	63	12
Metoprolol Tartrate	Metoprolol Tartrate	63	19
Tamsulosin Hcl	Tamsulosin Hcl	62	24
Tramadol Hcl	Tramadol Hcl	60	16
Clonazepam	Clonazepam	59	11
Doxycycline Hyclate	Doxycycline Hyclate	58	47
Citalopram Hbr	Citalopram Hydrobromide	57	12
Trazodone Hcl	Trazodone Hcl	56	18
Furosemide	Furosemide	54	18
Gabapentin	Gabapentin	52	18
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	52	13
Glipizide	Glipizide	50	14
Januvia	Sitagliptin Phosphate	49	13
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	48	13
Farxiga	Dapagliflozin Propanediol	48	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	47	14
Pioglitazone Hcl	Pioglitazone Hcl	46	19
Amoxicillin	Amoxicillin	44	30
Duloxetine Hcl	Duloxetine Hcl	42	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	42	12
Azithromycin	Azithromycin	41	33
Diazepam	Diazepam	40	suppressed
Allopurinol	Allopurinol	39	11
Escitalopram Oxalate	Escitalopram Oxalate	38	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	11
Pravastatin Sodium	Pravastatin Sodium	38	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	17
Glipizide Er	Glipizide	36	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	36	suppressed
Ibandronate Sodium	Ibandronate Sodium	35	suppressed
Carvedilol	Carvedilol	34	11
Clonidine Hcl	Clonidine Hcl	34	suppressed
Famotidine	Famotidine	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	33	12
Ezetimibe	Ezetimibe	33	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	suppressed
Jardiance	Empagliflozin	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Cephalexin	Cephalexin	30	21
Atenolol	Atenolol	29	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Cefuroxime	Cefuroxime Axetil	26	22
Lorazepam	Lorazepam	26	suppressed
Levofloxacin	Levofloxacin	25	25
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	22
Potassium Chloride	Potassium Chloride	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	20
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Sildenafil Citrate	Sildenafil Citrate	19	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Fluconazole	Fluconazole	16	11
Colchicine	Colchicine	15	suppressed
Ozempic	Semaglutide	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Finasteride	Finasteride	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Megestrol Acetate	Megestrol Acetate	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Testosterone	Testosterone	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Topiramate	Topiramate	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error